Botanical species · safety record

Ipomoea purga

The EFSA Compendium of Botanicals holds 8 constituent measurements and 2 adverse-effect records for Ipomoea purga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ipomoea purga (Wender.) Hayne

8Constituent measurements

2Safety records

3Cited sources

1Licensed products (Canada)

Also recorded as

Exogonium purga (Wender.) Benth.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Ipomoea purga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Whole flowering plant(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Glucoresins	Unspecified	—	—	—	Resolve DOI
Glucoresins	Stem / stalk	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Glucoresins	Seed	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Glucoresins	Leaves	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Glucoresins	Roots and other underground parts	Solvent extraction	21.4 Percent	Traditional analytical techniques (wet chemical tests)	No resolvable identifier
Lysergol	Stem / stalk	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Lysergol	Seed	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Lysergol	Roots and other underground parts	Solvent extraction	—	Chromatographic tests	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	—	—	Human (as organism)	Acute toxicity	Resolve DOI
Not stated	Digestive	—	—	Human (as organism)	Not reported	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Argaez, AG., PerezAmador, MC. Distribution in the plant of glycoresins and ergoline alkaloids in three species of Ipomoea (Convolvulaceae) . Phyton-international journal of experimental botany, 1997, vol. 60, p. 73-76.
Pereda-Miranda, Rogelio., Fragoso-Serrano, Mabel., Escalante-Sanchez, Edgar., Hernandez-Carlos, Beatriz., Linares, Edelmira., Bye, Robert. Profiling of the resin glycoside content of Mexican jalap roots with purgative activity . Journal of natural products, 2006, vol. 69, no. 10, p. 1460-1466. DOI
Meira, M., da Silva, E.P., David, J.M., David, J.P. Review of the genus Ipomoea: Traditional uses, chemistry and biological activities. Brazilian journal of pharmacognosy, 2012, vol. 22, no. 3, p. 682-713. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature